Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.54M | 3.54M | 3.06M | 3.06M | 3.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.54M | 3.54M | 3.06M | 3.06M | 3.05M |
| Cost of Revenue | 1.67M | 1.67M | 983.50K | 983.50K | 1.33M |
| Gross Profit | 1.86M | 1.86M | 2.08M | 2.08M | 1.72M |
| SG&A Expenses | 4.94M | 4.94M | 4.58M | 4.58M | 3.42M |
| Depreciation & Amortization | 637.00K | 637.00K | 636.00K | 636.00K | 592.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.35M | 7.35M | 6.32M | 6.32M | 5.35M |
| Operating Income | -3.81M | -3.81M | -3.26M | -3.26M | -2.30M |
| Income Before Tax | -36.00K | -36.00K | -2.44M | -2.44M | -2.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.00K | -36.00K | -2.44M | -2.44M | -2.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.00K | -36.00K | -2.44M | -2.44M | -2.19M |
| EBIT | -3.81M | -3.81M | -3.26M | -3.26M | -2.30M |
| EBITDA | -3.67M | -3.50M | -2.62M | -2.62M | -2.15M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 854.42M | 854.42M | 772.44M | 772.44M | 747.41M |
| Average Diluted Shares Outstanding | 854.42M | 854.42M | 772.44M | 772.44M | 747.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |